At Translucent, we recognise the importance of puberty blockers in healthcare options available to young people under 18 who are transgender. As part of this, we’ve written articles concerning puberty blockers in order to:
- Address misinformation: Our articles directly address misinformation and disinformation about puberty blockers.
- Present scientific evidence: Our articles aim to present scientific evidence regarding the safety and effectiveness of puberty blockers.
- Examine access to treatment: We examine accessibility to puberty blockers, including the impact of service specifications and referrals processes.
- Advocate for informed consent: Our articles advocate for informed consent and careful consideration in the use of gender-affirming hormone treatment.
- Challenge transphobic narratives: Our articles challenge transphobic narratives and talking points used in discussions about puberty blockers.
- Call out bias: We highlight bias and trans-hostile sentiments within reports and reviews related to puberty blockers.
- Promote policy changes: We advocate for policy changes that support access to puberty blockers.
- Emphasise risk vs. reward: Our articles address the risk versus reward of medicines and healthcare.
- Highlight the importance of access: Our articles highlight that puberty blockers have become an absolute necessity for some trans kids.
- Promote solidarity: Our articles emphasise the importance of solidarity and collective action across different communities to support trans rights and access to healthcare, including puberty blockers.
- Address the Cass Review: We address and critique the Cass Review, including the exclusion of trans people from the Assurance Group.
